BAROnova is a clinical-stage medical technology company developing endoscopically-delivered devices for the chronic treatment of obesity. The BAROnova technology focuses on slowing gastric emptying, a known mechanism of action for weight loss.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 02/18/13 | $27,300,000 | Series C |
Arboretum Ventures Boston Scientific Highland Capital Partners Lumira Capital ONSET Ventures | undisclosed |
| 11/24/15 | $36,500,000 | Series D |
Delos Capital Longitude Capital Lumira Capital ONSET Ventures | undisclosed |
